Literature DB >> 21056560

Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra.

Jason R Cannon1, Thomas Sew, Laura Montero, Edward A Burton, J Timothy Greenamyre.   

Abstract

Gene transfer to the central nervous system provides powerful methodology for the study of gene function and gene-environment interactions in vivo, in addition to a vehicle for the delivery of therapeutic transgenes for gene therapy. The aim of the present study was to determine patterns of tropism exhibited by pseudotyped lentiviral vectors in the rat substantia nigra, in order to evaluate their utility for gene transfer in experimental models of Parkinson's disease. Isogenic lentiviral vector particles encoding a GFP reporter were pseudotyped with envelope glycoproteins derived from vesicular stomatitis virus (VSV), Mokola virus (MV), lymphocytic choriomeningitis virus (LCMV), or Moloney murine leukemia virus (MuLV). Adult male Lewis rats received unilateral stereotactic infusions of vector into the substantia nigra; three weeks later, patterns of viral transduction were determined by immunohistological detection of GFP. Different pseudotypes gave rise to transgene expression in restricted and distinct cellular populations. VSV and MV pseudotypes transduced midbrain neurons, including a subset of nigral dopaminergic neurons. In contrast, LCMV- and MuLV-pseudotyped lentivirus produced transgene expression exclusively in astrocytes; the restricted transduction of astroglial cells was not explained by the cellular distribution of receptors previously shown to mediate entry of LCMV or MuLV. These data suggest that pseudotyped lentiviral vectors will be useful for experimental gene transfer to the rat substantia nigra. In particular, the availability of neuronal and astrocytic-targeting vectors will allow dissociation of cell autonomous and cell non-autonomous functions of key gene products in vivo.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056560      PMCID: PMC3038546          DOI: 10.1016/j.expneurol.2010.10.016

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  36 in total

1.  Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo.

Authors:  G P Kobinger; D J Weiner; Q C Yu; J M Wilson
Journal:  Nat Biotechnol       Date:  2001-03       Impact factor: 54.908

Review 2.  Neuropathology of Parkinson's disease.

Authors:  L S Forno
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

3.  Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.

Authors:  N Déglon; J L Tseng; J C Bensadoun; A D Zurn; Y Arsenijevic; L Pereira de Almeida; R Zufferey; D Trono; P Aebischer
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

4.  Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

Authors:  J C Bensadoun; N Déglon; J L Tseng; J L Ridet; A D Zurn; P Aebischer
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

5.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

6.  Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

Authors:  N Desmaris; A Bosch; C Salaün; C Petit; M C Prévost; N Tordo; P Perrin; O Schwartz; H de Rocquigny; J M Heard
Journal:  Mol Ther       Date:  2001-08       Impact factor: 11.454

7.  In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin.

Authors:  C Rosenblad; M Grønborg; C Hansen; N Blom; M Meyer; J Johansen; L Dagø; D Kirik; U A Patel; C Lundberg; D Trono; A Björklund; T E Johansen
Journal:  Mol Cell Neurosci       Date:  2000-02       Impact factor: 4.314

8.  Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.

Authors:  Winfried R Beyer; Manfred Westphal; Wolfram Ostertag; Dorothee von Laer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.

Authors:  Victor Tapias; Jason R Cannon; J Timothy Greenamyre
Journal:  J Neurosci Res       Date:  2010-02-01       Impact factor: 4.164

10.  Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

Authors:  A Auricchio; G Kobinger; V Anand; M Hildinger; E O'Connor; A M Maguire; J M Wilson; J Bennett
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

View more
  29 in total

Review 1.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

Review 2.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

Review 3.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

4.  Pseudo-typed Semliki Forest virus delivers EGFP into neurons.

Authors:  Fan Jia; Huan Miao; Xutao Zhu; Fuqiang Xu
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

5.  Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Maximilian G Schliesser; Cynthia C Bartholomae; Christof von Kalle; Manfred Schmidt; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2014-04-15       Impact factor: 5.695

Review 6.  Clinical applications involving CNS gene transfer.

Authors:  Boris Kantor; Thomas McCown; Paola Leone; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

7.  From the Cover: Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease Models.

Authors:  John Pierce Wise; Jason Cannon
Journal:  Toxicol Sci       Date:  2016-07-29       Impact factor: 4.849

8.  Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury.

Authors:  J L Gollihue; C M Norris
Journal:  Ageing Res Rev       Date:  2020-02-24       Impact factor: 10.895

9.  Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Emily M Rocha; Qing Bai; Amina El Ayadi; David Hinkle; Edward A Burton; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2018-04-09       Impact factor: 5.996

10.  Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.

Authors:  Jason R Cannon; Kindiya D Geghman; Victor Tapias; Thomas Sew; Michelle K Dail; Chenjian Li; J Timothy Greenamyre
Journal:  Exp Neurol       Date:  2012-11-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.